Simon Walsh

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

Timo Mäkikallio, Niels Ramsing Holm, Mitchell Lindsay et al. · The Lancet · 2016 · 773 citations · Full text

Medicine, Cardiology, Surgery +13

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

Niels Ramsing Holm, Timo Mäkikallio, Mitchell Lindsay et al. · The Lancet · 2019 · 440 citations

Medicine, Cardiology, Surgery +13

The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe

Joren Maeremans, Simon Walsh, Paul Knaapen et al. · Journal of the American College of Cardiology · 2016 · 311 citations

Dentistry, Oral Surgery, Surgery +8

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Javier Escaned, Carlos Collet, Nicola Ryan et al. · European Heart Journal · 2017 · 295 citations · Full text

Medicine, Cardiology, Surgery +17